Don’t forget to join us: escardio.org/Councils/Counci…
Membership is free - a multidisciplinary Council, with interested colleagues in heart-brain interactions #collaboration with scientific initiatives, position papers, translational science, webinars, blogs tinyurl.com/532ur22n
Thank you for an outstanding meeting in Milan🙏✨
Now, mark your calendars for next year!
#ESCHeartAndStroke & #EuroThrombosis 2026
🗓 13–14 November 2026
📍 Prague, Czech Republic 🇨🇿
Stay tuned for many updates!🚀
@escardio @LiverpoolCCS @JacopoImberti @ESCWGThrombosis
Liverpool Centre for Cardiovascular Science retweeted
🆕 Just published: 2026 APHRS Atrial Fibrillation Guidelines
These first comprehensive guidelines on AF draw on the latest research to advance personalized care across Asia-Pacific and beyond.
#AtrialFibrillation
👉 Explore: bit.ly/4sj78JH
Liverpool Centre for Cardiovascular Science retweeted
📢 JUST PUBLISHED! 2026 APHRS Atrial Fibrillation Guidelines—The First Comprehensive APHRS Guidelines on Atrial Fibrillation
onlinelibrary.wiley.com/doi/…
Liverpool Centre for Cardiovascular Science retweeted
▶️ Missed our AFFIRMO webinar? The recording is now available!
Last week, Professor Gregory Lip shared valuable insights on AFFIRMO’s evidence and its implications.
🎥 Watch the full recording on YouTube: youtu.be/ej5rfH25OnU?is=sl8O…
#AFFIRMO #AtrialFibrillation #IntegratedCare
AFFIRMO Webinar | From Evidence to Integrated Care youtu.be/ej5rfH25OnU?si=Xe4P… via @YouTube
Liverpool Centre for Cardiovascular Science retweeted
📢AFFIRMO shares its results in Sofia! 🇧🇬
Bulgarian investigators and international collaborators met alongside the national cardiology congress to discuss project findings and highlight the contribution of our partner, the Medical University of Plovdiv.
#AFFIRMO #Cardiology
Heart Plug or Blood Thinners? Landmark Analysis Reveals a Stroke Trade-Off in Atrial Fibrillation Care bioengineer.org/heart-plug-o…
Liverpool Centre for Cardiovascular Science retweeted
Socioeconomic deprivation and reclassification of ischemic stroke risk in patients with atrial fibrillation: A report from UK Biobank
heartrhythmjournal.com/artic…
Liverpool Centre for Cardiovascular Science retweeted
⏰2 days left!
Join Professor Gregory Y.H. Lip on 14 October, 12:00–13:00 CEST to discuss key project findings and lessons for implementation.
💻 Via Zoom
🔗Register here: us02web.zoom.us/meeting/regi…
Liverpool Centre for Cardiovascular Science retweeted
Prevalence and characteristics of patients with coronary heart disease and blood pressure below target: the INTERASPIRE study bit.ly/4mhtS9K
Liverpool Centre for Cardiovascular Science retweeted
On 30 September, Prof. Gregory Lip shared insights from AFFIRMO at @LivUni, meeting with around 30 PhD students and Clinical Fellows.
Learn more here: affirmo.eu/news/affirmo-find…
#AFFIRMO #AtrialFibrillation #IntegratedCare #KnowledgeExchange
Liverpool Centre for Cardiovascular Science retweeted
🧵..
Think u know ur #aspirin🟡? Think again!😂
Honored to share the design paper for #COATED_AIR,🥇large #RCT of coated vs plain aspirin @ESC_Journals @EditorEHJCVP. 🙏to partner w @psadeghipour @AzitaTalasaz & be supported by a🌟 team. 3000 pts in!✅👇
tinyurl.com/28zxmjzp
Liverpool Centre for Cardiovascular Science retweeted
Out Now! AFFIRMO Informative and guidance booklet for patients and carigivers
Check it out here! affirmo.eu/media/1255/en-boo…
Liverpool Centre for Cardiovascular Science retweeted
🎙️Listen to my interview w/prof. Y. Guo for #CardioTalkStroke Podcast!
We discuss on wearables, risk scoring, and ECG: from evidence to implementation
Available on all your favorite apps!
🖇️tinyurl.com/a7f9uyfy
@Fra_Vitali90 @escardio @EHRAPresident @LiverpoolCCS
Liverpool Centre for Cardiovascular Science retweeted
🚨 LAST CHANCE to shape the future of CoS Young!
The @escardio CoS is building a new community for young clinicians & researchers
Share your priorities, expectations & ideas through our survey.
⏳ Closing 4 October — have your say!!
🖇️tinyurl.com/59mdstem
@LiverpoolCCS
Liverpool Centre for Cardiovascular Science retweeted
Llevas años sumando factores de riesgo como si todos pesaran lo mismo. El registro GLORIA-AF acaba de poner números a esa suposición.
🧮 Una escala ponderada de 10 factores, de 0 a 23 puntos, derivada en 20.517 pacientes con fibrilación auricular de nuevo diagnóstico.
⚖️ La tromboembolia previa vale 5 puntos y la hiperlipidemia 1. El CHA2DS2-VA les da 2 y 0 respectivamente.
📈 Índice C de 0,661 frente a 0,626 del CHA2DS2-VA en derivación, y 0,652 frente a 0,616 en validación externa.
🔍 La mejora en reclasificación de los pacientes que sí sufren el ictus no se reproduce fuera de la cohorte donde nació la escala.
⚠️ Ojo con la función renal: los 4 puntos son para diálisis, trasplante o creatinina ≥ 2,26 mg/dL, no para cualquier enfermedad renal crónica.
🩺 Los propios autores lo dicen: complemento del CHA2DS2-VA, no sustituto, y ningún umbral validado para decidir anticoagulación.
cardioteca.com/arritmias/851…
Liverpool Centre for Cardiovascular Science retweeted
📍AFFIRMO research on display at #EuGMS2026!
AFFIRMO's presence at the EuGMS Congress 2026 also included a dedicated stand, providing an opportunity to share our research, connect with researchers and healthcare professionals, and exchange ideas.
#AFFIRMO #Multimorbidity
Liverpool Centre for Cardiovascular Science retweeted
🎙️Listen to our latest #CardioTalkStroke Podcast!
@JacopoImberti & prof. Y. Guo discuss on wearables, risk scoring, and ECG: from evidence to implementation
Available on all your favorite apps!
🖇️tinyurl.com/a7f9uyfy
@GiulioFRomiti @Fra_Vitali90 @escardio @EHRAPresident
Liverpool Centre for Cardiovascular Science retweeted
Huge congratulations to the whole team @PolishSmog — @ESCStrokeChair @AnnaKurasz_ and Sławomir Dobrzycki — for winning the award for the Best Original Research presented at the @PTKardio Congress! 🏆👏
A fantastic recognition of our collaborative work! ❤️
🎓PhD Opportunity: HEART–MIND AF ♥️🧠
🗓️ Deadline: 13th October 2026 @ 1pm
✉️ Contact @BuckleyBenjamin to discuss
#PhD #NIHR #ARCNWC #AtrialFibrillation #MentalHealth #CardiovascularHealth #HealthInequalities #CoDesign
Liverpool Centre for Cardiovascular Science retweeted
Cardiologists' tools learned in med school dominate (CHA2DS2-VA 85%, HAS-BLED 77%). Nephrology-specific tools lag despite clinical need (KFRE 39%, IgAN 33%, ADPKD MIC 26%). Disease-specific tools concentrate in academic centers; community settings rarely use them.



































